ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -31 مورد

Dosing regimens for treatment of tuberculosis infection (latent tuberculosis) in children

Dosing regimens for treatment of tuberculosis infection (latent tuberculosis) in children
Regimen Dosing
Isoniazid* and rifapentine (3HP) Isoniazid (orally once weekly for 3 months; direct observation is preferred):
  • For children ≥12 years, 15 mg/kg, rounded up to the nearest 50 or 100 mg; 900 mg maximum
  • For children ages 2 to 11: 25 mg/kg; 900 mg maximum

Rifapentine (orally once weekly for 3 months; direct observation is preferred):

  • 10 to 14 kg: 300 mg
  • 14.1 to 25 kg: 450 mg
  • 25.1 to 32 kg: 600 mg
  • 32.1 to 49.9 kg: 750 mg
  • ≥50 kg: 900 mg maximum
Rifampin (4R) Rifampin 15 to 20 mg/kg PO daily for 4 months; not to exceed 600 mg/dayΔ
Isoniazid* and rifampin (3HR)

Isoniazid 10 to 15 mg/kg PO daily for 3 months; not to exceed 300 mg/day

Rifampin 10 to 20 mg/kg PO daily for 3 months; not to exceed 600 mg/day
Isoniazid (9H)* Standard regimen:
  • Isoniazid 10 to 15 mg/kg PO daily for 9 months; not to exceed 300 mg/day

Alternate regimen:

  • Isoniazid 20 to 30 mg/kg PO twice weekly§ for 9 months; not to exceed 900 mg/day
The efficacy and toxicity of these regimens differ and some are appropriate only for certain patient populations. For a discussion of the approach to selecting a regimen for the treatment of TBI, refer to the UpToDate topic on treatment of TBI in children. Dosing assumes normal renal and hepatic function. For nonobese individuals, dosing for isoniazid and rifampin is based on actual body weight; optimal dosing for obese individuals has not been established.

PO: by mouth; TB: tuberculosis; TBI: tuberculosis infection.

* Isoniazid tablets may be crushed and mixed with a palatable food to improve adherence. In the United States, isoniazid is available as a suspension in sorbitol (50 mg per 5 mL); however, use of this formulation may be associated with diarrhea. Peripheral neuropathy can occur among patients on regimens containing isoniazid due to interference with metabolism of pyridoxine; this can be prevented with pyridoxine supplementation (25 to 50 mg daily). Administration of pyridoxine is especially important for patients with conditions that can predispose to neuropathy (including diabetes, uremia, alcoholism, malnutrition, and HIV infection) as well as in the setting of pregnancy and seizure disorders. Among children on isoniazid, pyridoxine is warranted for exclusively breastfed infants, children on meat- and milk-deficient diets, children with nutritional deficiencies, and children with symptomatic HIV infection.

¶ Pill burden is potential downside to use of 3HP in children. Rifapentine is available as 150 mg tablets with dose based on body weight; the rifapentine dose for a 25 kg child would be 450 mg (three tablets). The isoniazid dose is based on weight and age; if the 25 kg child is between ages 2 to 11, the isoniazid dose (25 mg/kg) would be 600 mg (two 300 mg tablets). Vitamin B6 (recommended for co-administration with isoniazid to children) would add a sixth tablet to each dose. Tablets may be crushed and administered in a palatable base.

Δ The American Academy of Pediatrics acknowledges that some experts use rifampin at 20 to 30 mg/kg for the daily regimen when prescribing for infants and toddlers.[1]

◊ For children in high-income countries treated with isoniazid, a regimen of daily isoniazid for 9 months is preferred. For children in resource-limited settings treated with isoniazid, we are in agreement with the World Health Organization, which recommends 6 months of daily therapy.

§ Twice-weekly regimens of isoniazid must be administered with directly observed therapy.
Reference:
  1. American Academy of Pediatrics. Red Book: 2024-2027 Report of the Committee on Infectious Diseases, 33rd ed, Kimberlin DW, Banerjee R, Barnett ED, et al (Eds), American Academy of Pediatrics 2024.

Adapted from:

  1. Blumberg HM, Leonard MK Jr, Jasmer RM. Update on treatment of tuberculosis and latent tuberculosis infection. JAMA 2005; 293:2776.
  2. Centers for Disease Control and Prevention (CDC). Recommendations for use of an isoniazid-rifapentine regimen with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR 2011; 60:1650.
  3. Villarino ME, Scott NA, Weis SE, et al. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr 2015; 169:247.
Graphic 117847 Version 8.0